2021
Limits of the Glasgow Coma Scale When Assessing for Sepsis in Allogeneic Hematopoietic Cell Transplant Recipients
Lind M, Rosas M, McFarland L, Taylor L, Olson S, Pergam S. Limits of the Glasgow Coma Scale When Assessing for Sepsis in Allogeneic Hematopoietic Cell Transplant Recipients. Nursing Research 2021, 70: 399-404. PMID: 34039938, PMCID: PMC9110054, DOI: 10.1097/nnr.0000000000000521.Peer-Reviewed Original ResearchConceptsAllogeneic hematopoietic cell transplant recipientsHematopoietic cell transplant recipientsAcute mental statusGlasgow Coma Scale scoreGlasgow Coma ScaleAcute mental status changesTransplant recipientsSuspected infectionMental status changesInfection onsetMental statusSepsis screening toolComa ScaleHigh-risk populationScreening toolModerate to high sensitivityRisk patientsStatus changesChart reviewGCS scoreSepsis developmentSepsisInfectionModerate sensitivityPatientsAre hematopoietic cell transplant recipients with Gram‐negative bacteremia spending more time outpatient while on intravenous antibiotics? Addressing trends over 10 years at a single center
Lind M, Roncaioli S, Liu C, Bryan A, Sweet A, Tverdek F, Sorror M, Phipps A, Pergam S. Are hematopoietic cell transplant recipients with Gram‐negative bacteremia spending more time outpatient while on intravenous antibiotics? Addressing trends over 10 years at a single center. Immunity Inflammation And Disease 2021, 9: 1786-1794. PMID: 34289529, PMCID: PMC8589361, DOI: 10.1002/iid3.486.Peer-Reviewed Original ResearchConceptsGram-negative rod bacteremiaAllogeneic HCT recipientsOutpatient antibiotic treatmentHematopoietic cell transplantationHCT recipientsProportion of treatment timePosttransplant complicationsAntibiotic treatmentAllogeneic hematopoietic cell transplantationHematopoietic cell transplant recipientsOutpatient settingAntibiotic treatment timeBroad-spectrum antibioticsIntravenous antibioticsCell transplantationTransplant recipientsDays posttransplantationTreatment optionsTreatment timePatientsTreatment managementComplicationsInfection characteristicsRecipientsAmbulatory care setting
2020
A Targeted Screening Program for Latent Tuberculosis Infection Among Hematopoietic Cell Transplant Recipients
Sosa-Moreno A, Narita M, Spitters C, Swetky M, Podczervinski S, Lind M, Holmberg L, Liu C, Edelstein R, Pergam S. A Targeted Screening Program for Latent Tuberculosis Infection Among Hematopoietic Cell Transplant Recipients. Open Forum Infectious Diseases 2020, 7: ofaa224. PMID: 32671130, PMCID: PMC7348235, DOI: 10.1093/ofid/ofaa224.Peer-Reviewed Original ResearchHematopoietic cell transplant recipientsTuberculin skin testLatent tuberculosis infectionQuantiFERON-TB GoldHematopoietic cell transplantationLatent tuberculosis infection testingElectronic medical recordsTargeted screening programScreening programRisk factorsTuberculosis infectionPrevalence of latent tuberculosis infectionTargeted tuberculin skin testingTuberculin skin test resultsProgression to active tuberculosisNegative QFT resultsElectronic medical record reviewRetrospective cohort studyLow-prevalence populationsQFT resultsCell transplantationTransplant recipientsActive tuberculosisLTBI testingSkin testPredictive Value of 3 Clinical Criteria for Sepsis (Quick Sequential Organ Failure Assessment, Systemic Inflammatory Response Syndrome, and National Early Warning Score) With Respect to Short-term Mortality in Allogeneic Hematopoietic Cell Transplant Recipients With Suspected Infections
Lind M, Phipps A, Mooney S, Liu C, Fohner A, Patel K, Ueda M, Pergam S. Predictive Value of 3 Clinical Criteria for Sepsis (Quick Sequential Organ Failure Assessment, Systemic Inflammatory Response Syndrome, and National Early Warning Score) With Respect to Short-term Mortality in Allogeneic Hematopoietic Cell Transplant Recipients With Suspected Infections. Clinical Infectious Diseases 2020, 72: 1220-1229. PMID: 32133490, PMCID: PMC8028104, DOI: 10.1093/cid/ciaa214.Peer-Reviewed Original ResearchConceptsSystemic inflammatory response syndromeHematopoietic cell transplantationSuspected infectionNational Early Warning ScoreShort-term mortalityAllogeneic hematopoietic cell transplant recipientsAllogeneic hematopoietic cell transplantationHematopoietic cell transplant recipientsSequential Organ Failure AssessmentPredictive valueInflammatory response syndromeOrgan Failure AssessmentAllogeneic HCT recipientsPopulation-specific criteriaImmunocompromised patientsCell transplantationImmunocompromised populationsTransplant recipientsResponse syndromeHCT recipientsClinical criteriaFailure AssessmentEarly Warning ScoreSepsis definitionEnd pointsAssessing the Relationship between Glasgow Coma Scale Scores and MS Documentation in Allogeneic Hematopoietic Cell Transplant Recipients with Suspected Infection
Maravilla-Rosas M, McFarland L, Taylor L, Olson S, Pergam S, Lind M. Assessing the Relationship between Glasgow Coma Scale Scores and MS Documentation in Allogeneic Hematopoietic Cell Transplant Recipients with Suspected Infection. Transplantation And Cellular Therapy 2020, 26: s84-s85. DOI: 10.1016/j.bbmt.2019.12.017.Peer-Reviewed Original ResearchSepsis screening toolAllogeneic hematopoietic cell transplant recipientsAllogeneic hematopoietic cell transplantationMental statusScreening toolSuspected infectionGCS scoreAccuracy of documentationSI onsetHealthcare staffRecord documentationClinical documentationHematopoietic cell transplant recipientsGlasgow Coma Scale scoreMeasure awarenessSequential Organ Failure AssessmentAssessment toolComa Scale scoreHematopoietic cell transplantationSearch termsMedical recordsOrgan Failure AssessmentChart reviewIndicator of sepsisScale scoreTrends in the Proportion of Time Spent Outpatient While Receiving Antibiotics for Treatment of Gram-Negative Rod Bacteremia Among Allogeneic Hematopoietic Cell Transplant Recipients
Lind M, Roncaioli S, Phipps A, Liu C, Bryant A, Sweet A, Pergam S. Trends in the Proportion of Time Spent Outpatient While Receiving Antibiotics for Treatment of Gram-Negative Rod Bacteremia Among Allogeneic Hematopoietic Cell Transplant Recipients. Transplantation And Cellular Therapy 2020, 26: s320-s321. DOI: 10.1016/j.bbmt.2019.12.343.Peer-Reviewed Original ResearchGram-negative rod bacteremiaAllogeneic HCT recipientsProportion of treatment timeHematopoietic cell transplantationMultidrug-resistant organismsHCT recipientsAllogeneic hematopoietic cell transplant recipientsInpatient intravenous antibiotic therapyAllogeneic hematopoietic cell transplantationHematopoietic cell transplant recipientsOutpatient settingIntravenous antibiotic therapySeverity of illnessMDR statusAntibiotic durationBlood culturesAntibiotic therapyCell transplantationTransplant recipientsReceiving antibioticsAdult patientsAntibiotic treatmentTreatment timeAntibiotic deliveryOutpatient management